7 results
8-K
EX-99.1
LYEL
Lyell Immunopharma, Inc.
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
for men with castration-resistant prostate cancer. She joined the Lyell Board in May 2021 and serves as the lead independent director for Blueprint
8-K
LYEL
Lyell Immunopharma, Inc.
30 Sep 21
Departure of Directors or Certain Officers
4:05pm
, its lead independent director, to serve as the interim Chair of the Board during Dr. Klausner’s absence. We do not anticipate the Leave to have any
S-8
EX-4.2
sg4nw4g9po6fld sc4
21 Jun 21
Registration of securities for employees
5:08pm
S-1/A
EX-3.4
lnjn5 fgmqi
9 Jun 21
IPO registration (amended)
7:12am
- Prev
- 1
- Next